Silivo O. Conte Center For Neuroscience Research

Mimi Baird had not seen or heard from her father since the Harvard-trained physician, tormented by severe bipolar disease, walked away from his family when she was 5 years old. Then, when she was in her mid-50s, a mysterious box arrived at her door. Read More

The eighth annual Conte Center Symposium will be held from noon to 5:30 p.m. on Friday, Oct. 9, in room 1220, Medical Research Building III. Read More

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders. Read More

Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder. Read More

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read More

(photo by Anne Rayner) Randy Blakely, Ph.D., left, shares a laugh with Jeremy Veenstra-VanderWeele, M.D., and Elisabeth Dykens, Ph.D., at the fifth annual Conte Center Symposium, held recently in the Vanderbilt Law School’s Flynn Auditorium. Entitled “The Younger Games: Serotonin Science Comes of Age,” the symposium featured presentations by… Read More

The fifth annual Conte Center Symposium will be held from 1-6:30 p.m. Friday, Nov. 2, in the Vanderbilt Law School’s Flynn Auditorium. Speakers include: Patricia Gaspar, M.D., Ph.D., Institut National de la Santé de la Recherche Médicale Elizabeth Hammock, Ph.D., Vanderbilt University Mark Ansorge, Ph.D., Columbia University Medical… Read More

An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail. Read More

A new mouse model offers the ability to better test how selective serotonin reuptake inhibitors (SSRIs) work and could lead to the development of new classes of anti-depressants. Read More